Zdrowie i gospodarka · 16/07/2026
Government Owned Invention Available for License: Chimeric Antigen Receptors Targeting the Gamma Delta (γδ) T-Cell Receptor
The National Cancer Institute (NCI) is seeking research co-development partners and/or licensees for a set of Chimeric Antigen Receptors (CARs) designed to target the gamma delta T-cell receptor, with the goal of developing new cancer treatments.